HeartFlow, Inc is a privately held company which seeks to prevent unnecessary invasive testing for coronary artery disease by analyzing CT scan data. Scan data is uploaded to HeartFlow through secure channels, analyzed, and then returned to clinicians who determine if sufficient blood is reaching the heart. HeartFlow is pre-IPO and is cleared for use by the FDA.
| Loading Documents... |
